NovaDel Pharma Issued U.S. Patents For Oral Spray Delivery Of Major Classes Of Pharmaceuticals

FLEMINGTON, N.J.--(BUSINESS WIRE)--Jan. 10, 2006--NovaDel Pharma, Inc. (AMEX:NVD) today announced the issuance of two patents by the USPTO that further strengthen the Company's intellectual property position in the oral spray delivery of pharmaceuticals. The issued patents cover the use of multiple classes of drugs in oral sprays, including those for the treatment of pain, central nervous system disorders and for anesthesia under Novadel's oral spray delivery system.